Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality Improvement Survey I.0: A Retrospective Data Analysis of Clinician Survey Responses Following the Utilization of the PrecivityADTM Blood Test for the Detection of Alzheimer's Disease Pathology (QUIP I)

NCT05477056 is registered in ClinicalTrials.gov with C2N Diagnostics as lead sponsor.

NCT NCT05477056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05477056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality Improvement Survey I.0: A Retrospective Data Analysis of Clinician Survey Responses Following the Utilization of the PrecivityADTM Blood Test for the Detection of Alzheimer's Disease Pathology (QUIP I)
Lead sponsor
C2N Diagnostics
Phase
Observational
Overall status
Completed
Start date
March 1, 2021
Completion date
October 6, 2022
Enrollment
366 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline, dementia, mild cognitive impairment